Global Alfuzosin Market

Alfuzosin Comprehensive Study by Type (5mg Tablets, 10mg Tablets), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2025

Alfuzosin Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Alfuzosin Market Scope
Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It is an alpha-adrenergic blocker that helps relax the muscles in the prostate and bladder neck, making it easier to urinate.

The market study is being classified by Type (5mg Tablets and 10mg Tablets), by Application (Hospital and Drug store) and major geographies with country level break-up.

Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Alfuzosin market throughout the predicted period.

Mylan N.V. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Apotex Inc.(Canada), Torrent Pharmaceuticals Ltd.(India), Sun Pharmaceutical Industries Limited (India), Aurobindo Pharma Limited (India), FARMAK, a.s.( Czechia), Wockhardt Ltd.(India), Excella GmbH & Co. KG (Germany) and Unipex (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cipla Limited (India), Unichem Laboratories (India) and Shenzzhen Haorui Industrial Dev, Co, LTD (China).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Alfuzosin market by Type, Application and Region.

On the basis of geography, the market of Alfuzosin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Drivers
  • Rising Demand from Adult Male to Treat Benign Prostatic Hyperplasia
  • Growing Problem of an Enlarged Prostate Gland

Opportunities
  • Rising Research and Development Activities in Emerging Countries
  • Growth in Demand for Alfuzosin in Developing Countries

Restraints
  • Lack of Awareness of Alfuzosin

Challenges
  • Cause Side Effects such as Light-headed Feeling, Chest Pain, etc


Key Target Audience
Alfuzosin Manufacturers, Alfuzosin Suppliers/ Distributors, Raw Material Suppliers, Pharma Industry and Reasecha and Development Organization

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • 5mg Tablets
  • 10mg Tablets
By Application
  • Hospital
  • Drug store
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand from Adult Male to Treat Benign Prostatic Hyperplasia
      • 3.2.2. Growing Problem of an Enlarged Prostate Gland
    • 3.3. Market Challenges
      • 3.3.1. Cause Side Effects such as Light-headed Feeling, Chest Pain, etc
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Alfuzosin, by Type, Application and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Alfuzosin (Value)
      • 5.2.1. Global Alfuzosin by: Type (Value)
        • 5.2.1.1. 5mg Tablets
        • 5.2.1.2. 10mg Tablets
      • 5.2.2. Global Alfuzosin by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Drug store
      • 5.2.3. Global Alfuzosin Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Alfuzosin (Volume)
      • 5.3.1. Global Alfuzosin by: Type (Volume)
        • 5.3.1.1. 5mg Tablets
        • 5.3.1.2. 10mg Tablets
      • 5.3.2. Global Alfuzosin by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Drug store
      • 5.3.3. Global Alfuzosin Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Alfuzosin (Price)
      • 5.4.1. Global Alfuzosin by: Type (Price)
  • 6. Alfuzosin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mylan N.V. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Apotex Inc.(Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Torrent Pharmaceuticals Ltd.(India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sun Pharmaceutical Industries Limited (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aurobindo Pharma Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. FARMAK, a.s.( Czechia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Wockhardt Ltd.(India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Excella GmbH & Co. KG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Unipex (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Alfuzosin Sale, by Type, Application and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Alfuzosin (Value)
      • 7.2.1. Global Alfuzosin by: Type (Value)
        • 7.2.1.1. 5mg Tablets
        • 7.2.1.2. 10mg Tablets
      • 7.2.2. Global Alfuzosin by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Drug store
      • 7.2.3. Global Alfuzosin Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Alfuzosin (Volume)
      • 7.3.1. Global Alfuzosin by: Type (Volume)
        • 7.3.1.1. 5mg Tablets
        • 7.3.1.2. 10mg Tablets
      • 7.3.2. Global Alfuzosin by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Drug store
      • 7.3.3. Global Alfuzosin Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Alfuzosin (Price)
      • 7.4.1. Global Alfuzosin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Alfuzosin: by Type(USD Million)
  • Table 2. Alfuzosin 5mg Tablets , by Region USD Million (2014-2019)
  • Table 3. Alfuzosin 10mg Tablets , by Region USD Million (2014-2019)
  • Table 4. Alfuzosin: by Application(USD Million)
  • Table 5. Alfuzosin Hospital , by Region USD Million (2014-2019)
  • Table 6. Alfuzosin Drug store , by Region USD Million (2014-2019)
  • Table 7. South America Alfuzosin, by Country USD Million (2014-2019)
  • Table 8. South America Alfuzosin, by Type USD Million (2014-2019)
  • Table 9. South America Alfuzosin, by Application USD Million (2014-2019)
  • Table 10. Brazil Alfuzosin, by Type USD Million (2014-2019)
  • Table 11. Brazil Alfuzosin, by Application USD Million (2014-2019)
  • Table 12. Argentina Alfuzosin, by Type USD Million (2014-2019)
  • Table 13. Argentina Alfuzosin, by Application USD Million (2014-2019)
  • Table 14. Rest of South America Alfuzosin, by Type USD Million (2014-2019)
  • Table 15. Rest of South America Alfuzosin, by Application USD Million (2014-2019)
  • Table 16. Asia Pacific Alfuzosin, by Country USD Million (2014-2019)
  • Table 17. Asia Pacific Alfuzosin, by Type USD Million (2014-2019)
  • Table 18. Asia Pacific Alfuzosin, by Application USD Million (2014-2019)
  • Table 19. China Alfuzosin, by Type USD Million (2014-2019)
  • Table 20. China Alfuzosin, by Application USD Million (2014-2019)
  • Table 21. Japan Alfuzosin, by Type USD Million (2014-2019)
  • Table 22. Japan Alfuzosin, by Application USD Million (2014-2019)
  • Table 23. India Alfuzosin, by Type USD Million (2014-2019)
  • Table 24. India Alfuzosin, by Application USD Million (2014-2019)
  • Table 25. South Korea Alfuzosin, by Type USD Million (2014-2019)
  • Table 26. South Korea Alfuzosin, by Application USD Million (2014-2019)
  • Table 27. Taiwan Alfuzosin, by Type USD Million (2014-2019)
  • Table 28. Taiwan Alfuzosin, by Application USD Million (2014-2019)
  • Table 29. Australia Alfuzosin, by Type USD Million (2014-2019)
  • Table 30. Australia Alfuzosin, by Application USD Million (2014-2019)
  • Table 31. Rest of Asia-Pacific Alfuzosin, by Type USD Million (2014-2019)
  • Table 32. Rest of Asia-Pacific Alfuzosin, by Application USD Million (2014-2019)
  • Table 33. Europe Alfuzosin, by Country USD Million (2014-2019)
  • Table 34. Europe Alfuzosin, by Type USD Million (2014-2019)
  • Table 35. Europe Alfuzosin, by Application USD Million (2014-2019)
  • Table 36. Germany Alfuzosin, by Type USD Million (2014-2019)
  • Table 37. Germany Alfuzosin, by Application USD Million (2014-2019)
  • Table 38. France Alfuzosin, by Type USD Million (2014-2019)
  • Table 39. France Alfuzosin, by Application USD Million (2014-2019)
  • Table 40. Italy Alfuzosin, by Type USD Million (2014-2019)
  • Table 41. Italy Alfuzosin, by Application USD Million (2014-2019)
  • Table 42. United Kingdom Alfuzosin, by Type USD Million (2014-2019)
  • Table 43. United Kingdom Alfuzosin, by Application USD Million (2014-2019)
  • Table 44. Netherlands Alfuzosin, by Type USD Million (2014-2019)
  • Table 45. Netherlands Alfuzosin, by Application USD Million (2014-2019)
  • Table 46. Rest of Europe Alfuzosin, by Type USD Million (2014-2019)
  • Table 47. Rest of Europe Alfuzosin, by Application USD Million (2014-2019)
  • Table 48. MEA Alfuzosin, by Country USD Million (2014-2019)
  • Table 49. MEA Alfuzosin, by Type USD Million (2014-2019)
  • Table 50. MEA Alfuzosin, by Application USD Million (2014-2019)
  • Table 51. Middle East Alfuzosin, by Type USD Million (2014-2019)
  • Table 52. Middle East Alfuzosin, by Application USD Million (2014-2019)
  • Table 53. Africa Alfuzosin, by Type USD Million (2014-2019)
  • Table 54. Africa Alfuzosin, by Application USD Million (2014-2019)
  • Table 55. North America Alfuzosin, by Country USD Million (2014-2019)
  • Table 56. North America Alfuzosin, by Type USD Million (2014-2019)
  • Table 57. North America Alfuzosin, by Application USD Million (2014-2019)
  • Table 58. United States Alfuzosin, by Type USD Million (2014-2019)
  • Table 59. United States Alfuzosin, by Application USD Million (2014-2019)
  • Table 60. Canada Alfuzosin, by Type USD Million (2014-2019)
  • Table 61. Canada Alfuzosin, by Application USD Million (2014-2019)
  • Table 62. Mexico Alfuzosin, by Type USD Million (2014-2019)
  • Table 63. Mexico Alfuzosin, by Application USD Million (2014-2019)
  • Table 64. Alfuzosin Sales: by Type(Unit)
  • Table 65. Alfuzosin Sales 5mg Tablets , by Region Unit (2014-2019)
  • Table 66. Alfuzosin Sales 10mg Tablets , by Region Unit (2014-2019)
  • Table 67. Alfuzosin Sales: by Application(Unit)
  • Table 68. Alfuzosin Sales Hospital , by Region Unit (2014-2019)
  • Table 69. Alfuzosin Sales Drug store , by Region Unit (2014-2019)
  • Table 70. South America Alfuzosin Sales, by Country Unit (2014-2019)
  • Table 71. South America Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 72. South America Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 73. Brazil Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 74. Brazil Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 75. Argentina Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 76. Argentina Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 77. Rest of South America Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 78. Rest of South America Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 79. Asia Pacific Alfuzosin Sales, by Country Unit (2014-2019)
  • Table 80. Asia Pacific Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 81. Asia Pacific Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 82. China Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 83. China Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 84. Japan Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 85. Japan Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 86. India Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 87. India Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 88. South Korea Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 89. South Korea Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 90. Taiwan Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 91. Taiwan Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 92. Australia Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 93. Australia Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 94. Rest of Asia-Pacific Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 95. Rest of Asia-Pacific Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 96. Europe Alfuzosin Sales, by Country Unit (2014-2019)
  • Table 97. Europe Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 98. Europe Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 99. Germany Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 100. Germany Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 101. France Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 102. France Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 103. Italy Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 104. Italy Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 105. United Kingdom Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 106. United Kingdom Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 107. Netherlands Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 108. Netherlands Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 109. Rest of Europe Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 110. Rest of Europe Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 111. MEA Alfuzosin Sales, by Country Unit (2014-2019)
  • Table 112. MEA Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 113. MEA Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 114. Middle East Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 115. Middle East Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 116. Africa Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 117. Africa Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 118. North America Alfuzosin Sales, by Country Unit (2014-2019)
  • Table 119. North America Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 120. North America Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 121. United States Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 122. United States Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 123. Canada Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 124. Canada Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 125. Mexico Alfuzosin Sales, by Type Unit (2014-2019)
  • Table 126. Mexico Alfuzosin Sales, by Application Unit (2014-2019)
  • Table 127. Alfuzosin: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Alfuzosin: by Type(USD Million)
  • Table 139. Alfuzosin 5mg Tablets , by Region USD Million (2020-2025)
  • Table 140. Alfuzosin 10mg Tablets , by Region USD Million (2020-2025)
  • Table 141. Alfuzosin: by Application(USD Million)
  • Table 142. Alfuzosin Hospital , by Region USD Million (2020-2025)
  • Table 143. Alfuzosin Drug store , by Region USD Million (2020-2025)
  • Table 144. South America Alfuzosin, by Country USD Million (2020-2025)
  • Table 145. South America Alfuzosin, by Type USD Million (2020-2025)
  • Table 146. South America Alfuzosin, by Application USD Million (2020-2025)
  • Table 147. Brazil Alfuzosin, by Type USD Million (2020-2025)
  • Table 148. Brazil Alfuzosin, by Application USD Million (2020-2025)
  • Table 149. Argentina Alfuzosin, by Type USD Million (2020-2025)
  • Table 150. Argentina Alfuzosin, by Application USD Million (2020-2025)
  • Table 151. Rest of South America Alfuzosin, by Type USD Million (2020-2025)
  • Table 152. Rest of South America Alfuzosin, by Application USD Million (2020-2025)
  • Table 153. Asia Pacific Alfuzosin, by Country USD Million (2020-2025)
  • Table 154. Asia Pacific Alfuzosin, by Type USD Million (2020-2025)
  • Table 155. Asia Pacific Alfuzosin, by Application USD Million (2020-2025)
  • Table 156. China Alfuzosin, by Type USD Million (2020-2025)
  • Table 157. China Alfuzosin, by Application USD Million (2020-2025)
  • Table 158. Japan Alfuzosin, by Type USD Million (2020-2025)
  • Table 159. Japan Alfuzosin, by Application USD Million (2020-2025)
  • Table 160. India Alfuzosin, by Type USD Million (2020-2025)
  • Table 161. India Alfuzosin, by Application USD Million (2020-2025)
  • Table 162. South Korea Alfuzosin, by Type USD Million (2020-2025)
  • Table 163. South Korea Alfuzosin, by Application USD Million (2020-2025)
  • Table 164. Taiwan Alfuzosin, by Type USD Million (2020-2025)
  • Table 165. Taiwan Alfuzosin, by Application USD Million (2020-2025)
  • Table 166. Australia Alfuzosin, by Type USD Million (2020-2025)
  • Table 167. Australia Alfuzosin, by Application USD Million (2020-2025)
  • Table 168. Rest of Asia-Pacific Alfuzosin, by Type USD Million (2020-2025)
  • Table 169. Rest of Asia-Pacific Alfuzosin, by Application USD Million (2020-2025)
  • Table 170. Europe Alfuzosin, by Country USD Million (2020-2025)
  • Table 171. Europe Alfuzosin, by Type USD Million (2020-2025)
  • Table 172. Europe Alfuzosin, by Application USD Million (2020-2025)
  • Table 173. Germany Alfuzosin, by Type USD Million (2020-2025)
  • Table 174. Germany Alfuzosin, by Application USD Million (2020-2025)
  • Table 175. France Alfuzosin, by Type USD Million (2020-2025)
  • Table 176. France Alfuzosin, by Application USD Million (2020-2025)
  • Table 177. Italy Alfuzosin, by Type USD Million (2020-2025)
  • Table 178. Italy Alfuzosin, by Application USD Million (2020-2025)
  • Table 179. United Kingdom Alfuzosin, by Type USD Million (2020-2025)
  • Table 180. United Kingdom Alfuzosin, by Application USD Million (2020-2025)
  • Table 181. Netherlands Alfuzosin, by Type USD Million (2020-2025)
  • Table 182. Netherlands Alfuzosin, by Application USD Million (2020-2025)
  • Table 183. Rest of Europe Alfuzosin, by Type USD Million (2020-2025)
  • Table 184. Rest of Europe Alfuzosin, by Application USD Million (2020-2025)
  • Table 185. MEA Alfuzosin, by Country USD Million (2020-2025)
  • Table 186. MEA Alfuzosin, by Type USD Million (2020-2025)
  • Table 187. MEA Alfuzosin, by Application USD Million (2020-2025)
  • Table 188. Middle East Alfuzosin, by Type USD Million (2020-2025)
  • Table 189. Middle East Alfuzosin, by Application USD Million (2020-2025)
  • Table 190. Africa Alfuzosin, by Type USD Million (2020-2025)
  • Table 191. Africa Alfuzosin, by Application USD Million (2020-2025)
  • Table 192. North America Alfuzosin, by Country USD Million (2020-2025)
  • Table 193. North America Alfuzosin, by Type USD Million (2020-2025)
  • Table 194. North America Alfuzosin, by Application USD Million (2020-2025)
  • Table 195. United States Alfuzosin, by Type USD Million (2020-2025)
  • Table 196. United States Alfuzosin, by Application USD Million (2020-2025)
  • Table 197. Canada Alfuzosin, by Type USD Million (2020-2025)
  • Table 198. Canada Alfuzosin, by Application USD Million (2020-2025)
  • Table 199. Mexico Alfuzosin, by Type USD Million (2020-2025)
  • Table 200. Mexico Alfuzosin, by Application USD Million (2020-2025)
  • Table 201. Alfuzosin Sales: by Type(Unit)
  • Table 202. Alfuzosin Sales 5mg Tablets , by Region Unit (2020-2025)
  • Table 203. Alfuzosin Sales 10mg Tablets , by Region Unit (2020-2025)
  • Table 204. Alfuzosin Sales: by Application(Unit)
  • Table 205. Alfuzosin Sales Hospital , by Region Unit (2020-2025)
  • Table 206. Alfuzosin Sales Drug store , by Region Unit (2020-2025)
  • Table 207. South America Alfuzosin Sales, by Country Unit (2020-2025)
  • Table 208. South America Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 209. South America Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 210. Brazil Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 211. Brazil Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 212. Argentina Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 213. Argentina Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 214. Rest of South America Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 215. Rest of South America Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 216. Asia Pacific Alfuzosin Sales, by Country Unit (2020-2025)
  • Table 217. Asia Pacific Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 218. Asia Pacific Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 219. China Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 220. China Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 221. Japan Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 222. Japan Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 223. India Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 224. India Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 225. South Korea Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 226. South Korea Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 227. Taiwan Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 228. Taiwan Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 229. Australia Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 230. Australia Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 231. Rest of Asia-Pacific Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 232. Rest of Asia-Pacific Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 233. Europe Alfuzosin Sales, by Country Unit (2020-2025)
  • Table 234. Europe Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 235. Europe Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 236. Germany Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 237. Germany Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 238. France Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 239. France Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 240. Italy Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 241. Italy Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 242. United Kingdom Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 243. United Kingdom Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 244. Netherlands Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 245. Netherlands Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 246. Rest of Europe Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 247. Rest of Europe Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 248. MEA Alfuzosin Sales, by Country Unit (2020-2025)
  • Table 249. MEA Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 250. MEA Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 251. Middle East Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 252. Middle East Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 253. Africa Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 254. Africa Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 255. North America Alfuzosin Sales, by Country Unit (2020-2025)
  • Table 256. North America Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 257. North America Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 258. United States Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 259. United States Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 260. Canada Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 261. Canada Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 262. Mexico Alfuzosin Sales, by Type Unit (2020-2025)
  • Table 263. Mexico Alfuzosin Sales, by Application Unit (2020-2025)
  • Table 264. Alfuzosin: by Type(USD/Units)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Alfuzosin: by Type USD Million (2014-2019)
  • Figure 5. Global Alfuzosin: by Application USD Million (2014-2019)
  • Figure 6. South America Alfuzosin Share (%), by Country
  • Figure 7. Asia Pacific Alfuzosin Share (%), by Country
  • Figure 8. Europe Alfuzosin Share (%), by Country
  • Figure 9. MEA Alfuzosin Share (%), by Country
  • Figure 10. North America Alfuzosin Share (%), by Country
  • Figure 11. Global Alfuzosin: by Type Unit (2014-2019)
  • Figure 12. Global Alfuzosin: by Application Unit (2014-2019)
  • Figure 13. South America Alfuzosin Share (%), by Country
  • Figure 14. Asia Pacific Alfuzosin Share (%), by Country
  • Figure 15. Europe Alfuzosin Share (%), by Country
  • Figure 16. MEA Alfuzosin Share (%), by Country
  • Figure 17. North America Alfuzosin Share (%), by Country
  • Figure 18. Global Alfuzosin: by Type USD/Units (2014-2019)
  • Figure 19. Global Alfuzosin share by Players 2019 (%)
  • Figure 20. Global Alfuzosin share by Players (Top 3) 2019(%)
  • Figure 21. Global Alfuzosin share by Players (Top 5) 2019(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Mylan N.V. (United States) Revenue: by Geography 2019
  • Figure 25. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 26. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2019
  • Figure 27. Apotex Inc.(Canada) Revenue, Net Income and Gross profit
  • Figure 28. Apotex Inc.(Canada) Revenue: by Geography 2019
  • Figure 29. Torrent Pharmaceuticals Ltd.(India) Revenue, Net Income and Gross profit
  • Figure 30. Torrent Pharmaceuticals Ltd.(India) Revenue: by Geography 2019
  • Figure 31. Sun Pharmaceutical Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 32. Sun Pharmaceutical Industries Limited (India) Revenue: by Geography 2019
  • Figure 33. Aurobindo Pharma Limited (India) Revenue, Net Income and Gross profit
  • Figure 34. Aurobindo Pharma Limited (India) Revenue: by Geography 2019
  • Figure 35. FARMAK, a.s.( Czechia) Revenue, Net Income and Gross profit
  • Figure 36. FARMAK, a.s.( Czechia) Revenue: by Geography 2019
  • Figure 37. Wockhardt Ltd.(India) Revenue, Net Income and Gross profit
  • Figure 38. Wockhardt Ltd.(India) Revenue: by Geography 2019
  • Figure 39. Excella GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Excella GmbH & Co. KG (Germany) Revenue: by Geography 2019
  • Figure 41. Unipex (France) Revenue, Net Income and Gross profit
  • Figure 42. Unipex (France) Revenue: by Geography 2019
  • Figure 43. Global Alfuzosin: by Type USD Million (2020-2025)
  • Figure 44. Global Alfuzosin: by Application USD Million (2020-2025)
  • Figure 45. South America Alfuzosin Share (%), by Country
  • Figure 46. Asia Pacific Alfuzosin Share (%), by Country
  • Figure 47. Europe Alfuzosin Share (%), by Country
  • Figure 48. MEA Alfuzosin Share (%), by Country
  • Figure 49. North America Alfuzosin Share (%), by Country
  • Figure 50. Global Alfuzosin: by Type Unit (2020-2025)
  • Figure 51. Global Alfuzosin: by Application Unit (2020-2025)
  • Figure 52. South America Alfuzosin Share (%), by Country
  • Figure 53. Asia Pacific Alfuzosin Share (%), by Country
  • Figure 54. Europe Alfuzosin Share (%), by Country
  • Figure 55. MEA Alfuzosin Share (%), by Country
  • Figure 56. North America Alfuzosin Share (%), by Country
  • Figure 57. Global Alfuzosin: by Type USD/Units (2020-2025)
List of companies from research coverage that are profiled in the study
  • Mylan N.V. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Apotex Inc.(Canada)
  • Torrent Pharmaceuticals Ltd.(India)
  • Sun Pharmaceutical Industries Limited (India)
  • Aurobindo Pharma Limited (India)
  • FARMAK, a.s.( Czechia)
  • Wockhardt Ltd.(India)
  • Excella GmbH & Co. KG (Germany)
  • Unipex (France)
Additional players considered in the study are as follows:
Cipla Limited (India) , Unichem Laboratories (India) , Shenzzhen Haorui Industrial Dev, Co, LTD (China)
Select User Access Type

Key Highlights of Report


Feb 2020 207 Pages 69 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Alfuzosin Market Quantitative research analysis
Global Alfuzosin Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Alfuzosin Market Report?

Have a Query? Click Here

Other Related Reports

Mesalamine Comprehensive Study by Type (Capsule, Tablets, Rectal Enema), Application (Hospital, Pharmacies, Medical Stores), Mode of Administration (Oral, Rectal), Dosage (250 mg, 375 mg, 400 mg, 500...
$ 3350
Iron Sucrose Injection Comprehensive Study by Application (Adult, Adolescents, Geriatric, Children), Distribution Channels (Online Pharmacy, Medical Stores, Hospital Pharmacy, Others), End User (Hosp...
$ 3650
Phosphate Binder Comprehensive Study by Type (Calcium Carbonate, Calcium Acetate, Sevelamer Hydrochloride, Lanthanum Carbonate, Magnesium Hydroxide, Sucroferric Oxyhydroxide, Ferric Citrate, Others),...
$ 3650
Milk Thistle Supplement Comprehensive Study by Application (Food Industry, Cosmetic Industry, Pharmaceutical Industry), Form (Capsules, Tablets, Soft gel), Distribution Channel (Hypermarket/Supermark...
$ 3650
Cancer Hormone Therapy Drugs Comprehensive Study by Application (Treat Prostate Cancer, Breast Cancers, Endometrial Cancer, Uterine Cancer, Other Cancer Treatments), Drug (Anti-Estrogen Drugs, Aromat...
$ 3750
Vitamin D Therapy Comprehensive Study by Type (Vitamin D3, Vitamin D2), Application (Pharmaceuticals, Functional Food & Beverages, Personal Care, Feed & Pet Food, Animal Feed, Pet Food, Supplements a...
$ 3750